Equipment used during PCI: Difference between revisions

Jump to navigation Jump to search
Tag: Replaced
 
Line 9: Line 9:
===[[PCI Equipment: Balloon Selection|Balloon Selection]]===
===[[PCI Equipment: Balloon Selection|Balloon Selection]]===
===[[PCI Equipment: Stent Selection|Stent Selection]]===
===[[PCI Equipment: Stent Selection|Stent Selection]]===
*[[Drug eluting stent]] ([[Drug eluting stent|DES]]) and [[bare metal stent]] ([[Bare metal stent|BMS]] are two main types of [[stents]] that are used during [[percutaneous coronary intervention]] ([[PCI]]).<ref name="pmid34895950">{{cite journal| author=Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM | display-authors=etal| title=2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=J Am Coll Cardiol | year= 2022 | volume= 79 | issue= 2 | pages= e21-e129 | pmid=34895950 | doi=10.1016/j.jacc.2021.09.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34895950  }} </ref>
*Compared to the fist generation of [[DES]], newer [[DES]] are optimized in [[drug]], polymer, and [[stent]] design. This significant evolution in [[DES]] technology leads to lower rate of [[stent]] [[thrombosis]] and [[mortality rate]].<ref name="pmid17145250">{{cite journal| author=Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL| title=Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. | journal=Am J Med | year= 2006 | volume= 119 | issue= 12 | pages= 1056-61 | pmid=17145250 | doi=10.1016/j.amjmed.2006.01.023 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17145250  }} </ref><ref name="pmid17296822">{{cite journal| author=Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L | display-authors=etal| title=Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. | journal=N Engl J Med | year= 2007 | volume= 356 | issue= 10 | pages= 1009-19 | pmid=17296822 | doi=10.1056/NEJMoa067722 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17296822  }} </ref><ref name="pmid15963413">{{cite journal| author=Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW| title=Late angiographic stent thrombosis (LAST) events with drug-eluting stents. | journal=J Am Coll Cardiol | year= 2005 | volume= 45 | issue= 12 | pages= 2088-92 | pmid=15963413 | doi=10.1016/j.jacc.2005.02.086 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15963413  }} </ref><ref name="pmid17020889">{{cite journal| author=Nordmann AJ, Briel M, Bucher HC| title=Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. | journal=Eur Heart J | year= 2006 | volume= 27 | issue= 23 | pages= 2784-814 | pmid=17020889 | doi=10.1093/eurheartj/ehl282 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17020889  }}  [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=17474675 Review in: ACP J Club. 2007 May-Jun;146(3):66] </ref>
*Currently available [[DES]] is superior to both first-generation [[DES]] and [[BMS]] due to higher efficacy and safety and lower [[restenosis]] rates.<ref name="pmid31056295">{{cite journal| author=Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P | display-authors=etal| title=Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. | journal=Lancet | year= 2019 | volume= 393 | issue= 10190 | pages= 2503-2510 | pmid=31056295 | doi=10.1016/S0140-6736(19)30474-X | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31056295  }} </ref><ref name="pmid26065988">{{cite journal| author=Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC | display-authors=etal| title=Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. | journal=J Am Coll Cardiol | year= 2015 | volume= 65 | issue= 23 | pages= 2496-507 | pmid=26065988 | doi=10.1016/j.jacc.2015.04.017 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26065988  }} </ref><ref name="pmid24459196">{{cite journal| author=Kang SH, Park KW, Kang DY, Lim WH, Park KT, Han JK | display-authors=etal| title=Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. | journal=Eur Heart J | year= 2014 | volume= 35 | issue= 17 | pages= 1147-58 | pmid=24459196 | doi=10.1093/eurheartj/eht570 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24459196  }} </ref><ref name="pmid24212107">{{cite journal| author=Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL | display-authors=etal| title=Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. | journal=BMJ | year= 2013 | volume= 347 | issue=  | pages= f6625 | pmid=24212107 | doi=10.1136/bmj.f6625 | pmc=3898413 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24212107  }} </ref>
*The following [[stents]] are listed from more safe to less safe based on several [[meta-analyses]]:<ref name="pmid31056295">{{cite journal| author=Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P | display-authors=etal| title=Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. | journal=Lancet | year= 2019 | volume= 393 | issue= 10190 | pages= 2503-2510 | pmid=31056295 | doi=10.1016/S0140-6736(19)30474-X | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31056295  }} </ref><ref name="pmid26065988">{{cite journal| author=Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC | display-authors=etal| title=Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. | journal=J Am Coll Cardiol | year= 2015 | volume= 65 | issue= 23 | pages= 2496-507 | pmid=26065988 | doi=10.1016/j.jacc.2015.04.017 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26065988  }} </ref><ref name="pmid24459196">{{cite journal| author=Kang SH, Park KW, Kang DY, Lim WH, Park KT, Han JK | display-authors=etal| title=Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. | journal=Eur Heart J | year= 2014 | volume= 35 | issue= 17 | pages= 1147-58 | pmid=24459196 | doi=10.1093/eurheartj/eht570 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24459196  }} </ref><ref name="pmid24212107">{{cite journal| author=Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL | display-authors=etal| title=Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. | journal=BMJ | year= 2013 | volume= 347 | issue=  | pages= f6625 | pmid=24212107 | doi=10.1136/bmj.f6625 | pmc=3898413 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24212107  }} </ref>
**Durable-polymer [[DES]]
**[[Biodegradable]]-polymer [[DES]]
**[[BMS]]
====ACA 2021 Revascularization Guideline====
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:lightgreen"|Class 1 Recommendation, Level of Evidence: A<ref name="pmid34895950">{{cite journal| author=Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM | display-authors=etal| title=2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=J Am Coll Cardiol | year= 2022 | volume= 79 | issue= 2 | pages= e21-e129 | pmid=34895950 | doi=10.1016/j.jacc.2021.09.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=34895950  }} </ref>
|-
| bgcolor="lightgreen"| [[DES]] is preferred over [[BMS]] in [[patients]] undergoing [[PCI]] to [[Prevention (medical)|prevent]] [[restenosis]], [[ST elevation myocardial infarction|MI]], or [[Stent thrombosis definition|acute stent thrombosis]].
|}


==References==
==References==

Latest revision as of 08:58, 22 June 2022

Percutaneous coronary intervention Microchapters

Home

Patient Information

Overview

Risk Stratification and Benefits of PCI

Preparation of the Patient for PCI

Equipment Used During PCI

Pharmacotherapy to Support PCI

Vascular Closure Devices

Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT

Post-PCI Management

Risk Reduction After PCI

Post-PCI follow up

Hybrid coronary revascularization

PCI approaches

PCI Complications

Factors Associated with Complications
Vessel Perforation
Dissection
Distal Embolization
No-reflow
Coronary Vasospasm
Abrupt Closure
Access Site Complications
Peri-procedure Bleeding
Restenosis
Renal Failure
Thrombocytopenia
Late Acquired Stent Malapposition
Loss of Side Branch
Multiple Complications

PCI in Specific Patients

Cardiogenic Shock
Left Main Coronary Artery Disease
Refractory Ventricular Arrhythmia
Severely Depressed Ventricular Function
Sole Remaining Conduit
Unprotected Left Main Patient
Adjuncts for High Risk PCI

PCI in Specific Lesion Types

Classification of the Lesion
The Calcified Lesion
The Ostial Lesion
The Angulated or Tortuous Lesion
The Bifurcation Lesion
The Long Lesion
The Bridge Lesion
Vasospasm
The Chronic Total Occlusion
The Left Internal Mammary Artery
Multivessel Disease
Distal Anastomotic Lesions
Left Main Intervention
The Thrombotic Lesion

Equipment used during PCI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Equipment used during PCI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Equipment used during PCI

CDC on Equipment used during PCI

Equipment used during PCI in the news

Blogs on Equipment used during PCI

Directions to Hospitals Treating Percutaneous coronary intervention

Risk calculators and risk factors for Equipment used during PCI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Equipments Used During PCI

Guiding Catheter Selection

Guidewire Selection

Balloon Selection

Stent Selection

References

Template:WH Template:WS